Arkolith/Insider Trading/CMMB/Form 4

Mor George Adi

Chief Executive Officer, DirectorChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Jun 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$20K
Net Open-Market Flow
-$20K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 29, 2026Sell(P)5K$2.05$10K134K
May 29, 2026Sell(P)5K$2.08$10K139K
May 29, 2026Other(J)32K——32K
May 29, 2026Other(J)19K——19K

Transaction Codes

P
Open-market purchase
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-26-003004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Chemomab Therapeutics Ltd.

Build

Ask your agent about CMMB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001178913-26-003004"
Ask your agent
Use Arkolith to summarize insider buying and selling at Chemomab Therapeutics Ltd.
over the last 90 days and cite the filings.